
Rhovica Secures Funding for Critical Neurosurgical Innovation
In a pivotal move for emergency healthcare, Rhovica Neuroimaging, a Bern-based startup, has successfully raised €2.5 million to enhance the development of its innovative SoNav system. This bedside navigation technology aims to streamline the placement of extraventricular drainage (EVD) catheters—an essential procedure for patients facing life-threatening increases in intracranial pressure. The funding round was notably led by M2care, with support from Kickfund and various angel investors.
Co-founder and CEO Martin Hlavica underscored the significance of this investment, stating, “This fundraising marks an important milestone for Rhovica. The trust of our investors strengthens our ability to advance the development of SoNav and move closer to making this solution available to patients in need.” Founded in 2023 by neurosurgeons, Rhovica is poised to challenge the traditional methods of EVD placement, which are often performed with speed but lack precision—resulting in potentially poor patient outcomes.
Transforming Emergency Neurosurgery
The SoNav system leverages integrated sensors to provide real-time visualization for guided catheter insertion at the bedside, a critical advancement considering the current reliance on freehand placement or cumbersome operating room navigation systems. Florence Thueux, President of M2care, remarked, “Rhovica reflects our approach: addressing a clear clinical need with a strong team and technology that can transform emergency neurosurgery.”
Market Potential and Future Outlook
Rhovica’s innovative approach positions it strategically within a rapidly growing neurosurgical device market, forecasted to expand between 4.5% and 14.2% in the upcoming years. The backing of experienced leaders like Carsten Laue into Rhovica’s board further accentuates the startup's potential for growth and impact in the field of health technology.
Call to Action: Invest in the Future of HealthTech
As the healthcare landscape evolves, the intersection of technology and patient care is more vital than ever. Financial institutions and service providers should consider supporting promising startups like Rhovica that are pioneering advancements in emergency medical technology.
Write A Comment